Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Japanese (NIKKEI) Biotech Industry Analysis

UpdatedMay 01, 2026
DataAggregated Company Financials
Companies34
  • 7D-4.4%
  • 3M2.1%
  • 1Y-2.4%
  • YTDn/a

Over the last 7 days, the Biotech industry has dropped 4.4%, driven by a pullback from Oncolys BioPharma of 8.5%. Over the last year, the industry has been flat overall. Looking forward, earnings are forecast to grow by 40% annually.

Industry Valuation and Performance

Has the Japanese Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 01 May 2026JP¥1.1tJP¥202.7b-JP¥49,271,096,682.0060.8x-22.7x5.5x
Sun, 29 Mar 2026JP¥1.1tJP¥202.7b-JP¥49,460,354,682.0056.6x-23.2x5.6x
Tue, 24 Feb 2026JP¥1.2tJP¥200.5b-JP¥50,373,794,682.00306.8x-23.6x5.9x
Thu, 22 Jan 2026JP¥1.1tJP¥198.7b-JP¥70,406,297,000.0061x-15.7x5.6x
Sat, 20 Dec 2025JP¥953.3bJP¥198.7b-JP¥70,727,642,000.0053.9x-13.5x4.8x
Mon, 17 Nov 2025JP¥1.1tJP¥194.7b-JP¥68,616,328,000.0053.8x-15.9x5.6x
Wed, 15 Oct 2025JP¥1.2tJP¥197.7b-JP¥65,794,561,000.0062.1x-17.7x5.9x
Fri, 12 Sep 2025JP¥1.2tJP¥193.5b-JP¥68,135,862,000.00112.2x-17.1x6x
Sun, 10 Aug 2025JP¥1.2tJP¥191.3b-JP¥66,643,319,000.00128x-17.8x6.2x
Tue, 08 Jul 2025JP¥1.0tJP¥218.2b-JP¥43,671,220,000.0098.2x-24x4.8x
Thu, 05 Jun 2025JP¥1.2tJP¥214.8b-JP¥40,595,705,000.0014.9x-30.5x5.8x
Sat, 03 May 2025JP¥1.1tJP¥207.8b-JP¥39,129,850,000.0015x-27.5x5.2x
Mon, 31 Mar 2025JP¥1.1tJP¥207.8b-JP¥39,285,612,000.0015.8x-26.8x5.1x
Wed, 26 Feb 2025JP¥1.1tJP¥207.4b-JP¥38,725,942,000.0015.2x-27.2x5.1x
Fri, 24 Jan 2025JP¥981.0bJP¥207.3b-JP¥13,514,452,000.0020.4x-72.6x4.7x
Sun, 22 Dec 2024JP¥1.0tJP¥206.4b-JP¥12,718,809,000.0022.4x-82x5.1x
Tue, 19 Nov 2024JP¥1.0tJP¥207.4b-JP¥10,788,549,000.0019.5x-94x4.9x
Thu, 17 Oct 2024JP¥1.1tJP¥214.3b-JP¥3,905,356,000.0022x-283.1x5.2x
Sat, 14 Sep 2024JP¥1.0tJP¥210.1b-JP¥469,229,000.0018.5x-2217.7x5x
Mon, 12 Aug 2024JP¥948.4bJP¥213.8bJP¥1.8b13.9x516.5x4.4x
Wed, 10 Jul 2024JP¥1.0tJP¥187.7b-JP¥15,773,047,000.0092.2x-64.3x5.4x
Fri, 07 Jun 2024JP¥814.3bJP¥195.7b-JP¥14,113,284,000.0095.9x-57.7x4.2x
Sun, 05 May 2024JP¥801.3bJP¥199.1b-JP¥14,617,545,000.0077.4x-54.8x4x
Tue, 02 Apr 2024JP¥764.7bJP¥194.2b-JP¥15,458,035,000.0060.9x-49.5x3.9x
Thu, 29 Feb 2024JP¥869.9bJP¥196.2b-JP¥19,179,997,000.0068.2x-45.4x4.4x
Sat, 27 Jan 2024JP¥779.2bJP¥222.3b-JP¥12,604,827,000.0017.6x-61.8x3.5x
Mon, 25 Dec 2023JP¥773.1bJP¥224.2b-JP¥12,970,409,000.0016.8x-59.6x3.4x
Wed, 22 Nov 2023JP¥796.0bJP¥221.9b-JP¥12,426,487,000.0017.2x-64.1x3.6x
Fri, 20 Oct 2023JP¥751.6bJP¥223.0b-JP¥14,478,735,000.0021.1x-51.9x3.4x
Sun, 17 Sep 2023JP¥886.1bJP¥225.3b-JP¥16,963,735,000.0027.6x-52.2x3.9x
Tue, 15 Aug 2023JP¥852.1bJP¥219.4b-JP¥18,857,181,000.0049.6x-45.2x3.9x
Thu, 13 Jul 2023JP¥913.5bJP¥223.0b-JP¥19,224,669,000.0053.5x-47.5x4.1x
Sat, 10 Jun 2023JP¥967.6bJP¥220.6b-JP¥21,578,670,000.0046.3x-44.8x4.4x
Mon, 08 May 2023JP¥892.4bJP¥218.2b-JP¥20,061,938,000.0020.8x-44.5x4.1x
Price to Earnings Ratio

-44.5x


Total Market Cap: JP¥892.4bTotal Earnings: -JP¥20,061,938,000.00Total Revenue: JP¥218.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Biotech Industry Price to Earnings3Y Average -115.5x202420252026
Current Industry PE
  • Investors are optimistic on the Japanese Biotechnology industry, and appear confident in long term growth rates.
  • The 3-year average PS ratio of 4.8x is lower than the industry's current PS ratio of 5.5x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
  • Revenues have also declined 2.4% per year.
  • This means overall sales from these companies are declining and losses are subsequently expanding as well.

Industry Comparison

How does Japanese Biotech compare with similar industries?

JP Market0.22%
Healthcare-2.78%
Biotech-4.39%
Biotech-4.39%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4587 PeptiDreamJP¥1.17k0.9%
+JP¥1.4b		-42.1%PS8.2x
177A Kohjin BioJP¥1.47k10.2%
+JP¥695.2m		-13.8%PE13.4x
4883 Modalis TherapeuticsJP¥66.0011.9%
+JP¥626.9m		-12.0%PB2.1x
4563 AnGesJP¥54.001.9%
+JP¥395.6m		-30.8%PS24.4x
4891 TMSJP¥149.003.5%
+JP¥227.4m		10.4%PB2.4x

Latest News

4883
JP¥66.00
Modalis Therapeutics
7D
11.9%
1Y
-12.0%

Here's Why We're Watching Modalis Therapeutics' (TSE:4883) Cash Burn Situation

Apr 29
Here's Why We're Watching Modalis Therapeutics' (TSE:4883) Cash Burn Situation
7777
JP¥504.00
3-D Matrix
7D
-2.7%
1Y
284.7%
4587
JP¥1,168.50
PeptiDream
7D
0.9%
1Y
-42.1%

4587: Out Licensing Milestones Will Eventually Support Stronger Long Term Earnings Visibility

Analysts have reduced their price target on PeptiDream to ¥1,600 from ¥2,700, citing slower than expected progress in product out-licensing as the main reason for the adjustment. Analyst Commentary Bullish Takeaways Bullish analysts still see value at the revised price target of ¥1,600, arguing that expectations now better reflect the current pace of out-licensing activity.
4597
JP¥32.00
Solasia Pharma K.K
7D
-8.6%
1Y
0%

We're Hopeful That Solasia Pharma K.K (TSE:4597) Will Use Its Cash Wisely

Apr 17
We're Hopeful That Solasia Pharma K.K (TSE:4597) Will Use Its Cash Wisely
4592
JP¥1,975.00
SanBio
7D
-3.6%
1Y
-14.1%
4891
JP¥149.00
TMS
7D
3.5%
1Y
10.4%
4593
JP¥332.00
Healios K.K
7D
-4.6%
1Y
2.8%
190A
JP¥153.00
Chordia Therapeutics
7D
1.3%
1Y
-33.5%
4563
JP¥54.00
AnGes
7D
1.9%
1Y
-30.8%
2160
JP¥3,020.00
GNI Group
7D
-3.5%
1Y
25.1%
4893
JP¥151.00
Noile-Immune Biotech
7D
0.7%
1Y
4.1%
177A
JP¥1,465.00
Kohjin Bio
7D
10.2%
1Y
-13.8%
504A
JP¥605.00
Innovacell
7D
-6.3%
1Y
n/a
4894
JP¥6,640.00
Cuorips
7D
-4.6%
1Y
-4.3%
4588
JP¥2,726.00
Oncolys BioPharma
7D
-8.5%
1Y
374.9%
4598
JP¥198.00
Delta-Fly Pharma
7D
0.5%
1Y
-56.6%